BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//132.216.98.100//NONSGML kigkonsult.se iCalcreator 2.20.4//
BEGIN:VEVENT
UID:20250923T002154EDT-2931JsH7FI@132.216.98.100
DTSTAMP:20250923T042154Z
DESCRIPTION:Lung cancer is our most fatal malignancy\, accounting for 28% o
 f all cancer-related deaths. In fact\, more people die from lung cancer th
 an breast\, colon and prostate cancer combined. Approximately two thirds o
 f patients with non-small cell lung cancer (NSCLC – accounts for 85% of al
 l lung cancers) will present with surgically unresectable disease and thos
 e with “curable” disease frequently go on to develop loco-regional and/or 
 distant metastasis\, the result of which ultimately leads to death. Immuno
 therapy has shown great promise with improved outcomes and prolonged survi
 val in a wide variety of cancers\, including NSCLC. However\, there is roo
 m for improvement as objective response rates are ~20-50%\, depending on p
 atient selection criteria and therapeutic combinations. Currently\, approx
 imately 60% of all NSCLC patients treated with immunotherapy will fail to 
 respond and an even larger proportion will fail to respond to systemic che
 motherapy. The need for improved systemic therapies for this disease is un
 mistakable and our lab uses both computational and traditional wet lab app
 roaches to identify and validate novel regulators of cancer progression. 
 \n
DTSTART:20191025T150000Z
DTEND:20191025T160000Z
LOCATION:Room 1034\, McIntyre Medical Building\, CA\, QC\, Montreal\, H3G 1
 Y6\, 3655 promenade Sir William Osler
SUMMARY:Seminar: Integrated approaches to uncover regulators of cancer prog
 ression
URL:/physiology/channels/event/seminar-integrated-appr
 oaches-uncover-regulators-cancer-progression-301099
END:VEVENT
END:VCALENDAR